This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: New York University. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Innovations of Edwin J Vazquez-Cintron
Introduction
Edwin J Vazquez-Cintron is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of T cell effector functions. With a total of 2 patents, his work has the potential to impact cancer treatment and immunotherapy.
Latest Patents
His latest patents include innovative methods and agents for modulating protocadherin-18 activity. These patents describe screening assays and methods for identifying modulator agents or compounds that affect pcdh18 mediated inhibition of T cell effector function. The pharmaceutical and immunogenic compositions he developed comprise agents that modulate this inhibition, which is particularly relevant for treating adenocarcinoma, a tumor type that expresses pcdh18. Additionally, he has developed treatment methods using atoxic neurotoxin derivatives, which involve contacting a subject with an isolated, physiologically active, atoxic derivative of a Clostridial neurotoxin to treat various conditions.
Career Highlights
Edwin J Vazquez-Cintron is affiliated with New York University, where he continues to advance his research and innovations. His work is characterized by a strong focus on the intersection of immunology and cancer therapy.
Collaborations
He collaborates with esteemed colleagues such as Jeremy C Burns and Alan B Frey, contributing to a dynamic research environment that fosters innovation.
Conclusion
Edwin J Vazquez-Cintron's contributions to biotechnology and cancer treatment through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in immunotherapy and cancer treatment strategies.